About Mindbloom
Mindbloom is an American telehealth company founded in 2018 that offers clinician-prescribed, at-home ketamine therapy programs for adults experiencing anxiety, depression, and PTSD. The platform connects clients with licensed psychiatric clinicians who prescribe sublingual ketamine tablets, supported by psychedelic guides and science-backed treatment protocols. It serves clients across dozens of U.S. states and has facilitated hundreds of thousands of therapy sessions.
Company details
Funding
Total raised
$44.9M
Last stage
Series B
Investors
Founders
Dylan Beynon
Founder and CEO of Mindbloom. Previously co-founded Mighty (Chief Growth Officer) and Voter's Friend (acquired by Democracy.com in 2014). Educated at the Wharton School of the University of Pennsylvania.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.